Medicare Part D coverage · doxycycline hyclate · RxCUI 1650446
doxycycline hyclate 150 MG Oral Tablet
Per the CMS 2026 Part D formulary file, doxycycline hyclate 150 MG Oral Tablet is covered by 33 Medicare Part D plans (0.7% of enrollable products), averaging Tier 1.8, with prior authorization required on 0% of covering formularies.
- 0.7%
- Plan coverage
- 33
- Plans covering
- T1.8
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for doxycycline hyclate 150 MG Oral Tablet
Per the CMS 2026 Part D formulary file, doxycycline hyclate 150 MG Oral Tablet (RxNorm concept RXCUI 1650446, generic name doxycycline hyclate) appears on 5 distinct formulary files spanning 33 Medicare Part D plan offerings - 0.7% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 1.8.
Real-world access to doxycycline hyclate 150 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 4,121,486 Part D beneficiaries filled doxycycline hyclate 150 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $117,336,811 and an average per-beneficiary annual cost of $28.47. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry doxycycline hyclate 150 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 5
- Plans covering
- 33
- Coverage rate
- 0.7%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 4,121,486
- Total spending
- $117,336,811
- Avg per beneficiary
- $28.47
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering doxycycline hyclate 150 MG Oral Tablet
33 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| CareAdvantage (HMO D-SNP) | SAN Mateo Health Commission | T1 | No | $0 | CA |
| Community Care's Partnership Program (HMO D-SNP) | Community Care Health Plan, Inc. | T1 | No | $0 | WI |
| Tufts Health One Care (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health One Care CW (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options CW (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
| MMM Supremo (HMO C-SNP) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Diamante Platino (HMO D-SNP) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Unico (HMO-POS) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Elite (HMO-POS) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Deluxe (HMO-POS) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Dorado Platino (HMO D-SNP) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| PMC Premier Platino (HMO D-SNP) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| PMC Max (HMO-POS) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Plenitud (HMO-POS) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Valioso (HMO-POS) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Combo Platino (HMO D-SNP) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Flexi Platino (HMO D-SNP) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Grandioso (HMO-POS) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Mega Flex (HMO-POS) | MMM Healthcare, LLC | T2 | No | $0 | PR |
Show the next 13 plans
| MMM Relax Platino (HMO D-SNP) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| MMM Balance (HMO-POS) | MMM Healthcare, LLC | T2 | No | $0 | PR |
| CarePartners Access (PPO) | Carepartners OF Connecticut, Inc. | T4 | No | $0 | CT |
| Tufts Medicare Preferred HMO Basic Rx (HMO) | Tufts Associated Health Maintenance Organization | T4 | No | $0 | MA |
| Tufts Medicare Preferred HMO Smart Saver Rx (HMO) | Tufts Associated Health Maintenance Organization | T4 | No | $0 | MA |
| CarePartners of CT CareAdvantage Preferred (HMO) | Carepartners OF Connecticut, Inc. | T4 | No | $0 | CT |
| Tufts Medicare Preferred PPO RX (PPO) | Tufts Associated Health Maintenance Organization | T4 | No | $0 | MA |
| Tufts Medicare Preferred HMO Value Rx (HMO) | Tufts Associated Health Maintenance Organization | T4 | No | $14.60 | MA |
| Tufts Medicare Preferred HMO Basic Rx (HMO) | Tufts Associated Health Maintenance Organization | T4 | No | $21.90 | MA |
| Tufts Medicare Preferred HMO Prime Rx (HMO) | Tufts Associated Health Maintenance Organization | T4 | No | $25.90 | MA |
| Tufts Medicare Preferred HMO Prime Rx (HMO) | Tufts Associated Health Maintenance Organization | T4 | No | $40.90 | MA |
| Tufts Medicare Preferred HMO Value Rx (HMO) | Tufts Associated Health Maintenance Organization | T4 | No | $46.90 | MA |
| Tufts Medicare Preferred HMO Prime Rx Plus (HMO) | Tufts Associated Health Maintenance Organization | T4 | No | $68.00 | MA |
Frequently Asked Questions
Is doxycycline hyclate 150 MG Oral Tablet covered by Medicare Part D?
Yes, doxycycline hyclate 150 MG Oral Tablet is covered by 33 Medicare Part D plans (0.7% of all Part D formularies).
What tier is doxycycline hyclate 150 MG Oral Tablet on Medicare Part D plans?
doxycycline hyclate 150 MG Oral Tablet averages Tier 1.8 across Part D plans, ranging from Tier 1 to Tier 4.
Does doxycycline hyclate 150 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for doxycycline hyclate 150 MG Oral Tablet. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on doxycycline hyclate 150 MG Oral Tablet?
In 2023, total Medicare Part D spending on doxycycline hyclate 150 MG Oral Tablet was $117,336,811, covering 4,121,486 beneficiaries. The average spend per beneficiary was $28.47.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- 2 ML methotrexate 25 MG/ML Injection T1.8
- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet T1.8
- hydrocortisone 25 MG/ML Topical Cream T1.8
- ketorolac tromethamine 5 MG/ML Ophthalmic Solution T1.8
- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution T1.8
- mirtazapine 7.5 MG Oral Tablet T1.8
Similar prior-authorization rate
- metronidazole 10 MG/ML Topical Cream [Noritate] 0% PA
- 24 HR minocycline 40 MG Extended Release Oral Capsule [Emrosi] 0% PA
- buspirone hydrochloride 10 MG Oral Capsule [Bucapsol] 0% PA
- diflunisal 375 MG Oral Tablet [Dolobid] 0% PA
- hydrocortisone 1 MG/ML Oral Solution [Khindivi] 0% PA
- indomethacin 50 MG Rectal Suppository [Indocin] 0% PA